Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
5th May 2026 Uncategorised 0
Findings support once‑daily dosing and reinforce PALI‑2108’s potential

More: Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
Source: News
